Genomic surveillance SARS-CoV2, preliminary phase
- Funded by State Secretariat for Education, Research, and Innovation SERI (Staatssekretariat für Bildung, Forschung und Innovation)
- Total publications:0 publications
Grant number: 0142004471
Grant search
Key facts
Disease
COVID-19Start & end year
20202021Known Financial Commitments (USD)
$1,320,632.57Funder
State Secretariat for Education, Research, and Innovation SERI (Staatssekretariat für Bildung, Forschung und Innovation)Principal Investigator
Bourqui-Pittet MartineResearch Location
N/ALead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Pathogen genomics, mutations and adaptations
Special Interest Tags
N/A
Study Type
Not applicable
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
The course of the pandemic due to the Coronavirus SARS-CoV 2 is influenced by the virus strains in circulation. Certain strains may have decisive epidemiological characteristics such as greater contagiousness, cause more serious developments of the disease, reduce the effectiveness of a vaccine, etc. In December 2020, strains of the so-called English variant or Alpha variant began to be in circulation and suggested a more contagious strain. It was urgent to set up a genomic surveillance system by sequencing a certain number of coronavirus-positive samples. ETHZ, through the Science Task Force and Professor Stadler, have made their laboratories, resources and skills available for the implementation ...